Regenerative medicine focuses on restoring or replacing damaged tissues and organs through the integration of stem cell biology, tissue engineering, and biomaterials science. This interdisciplinary field employs techniques such as scaffold fabrication, cellular reprogramming, and gene editing to promote tissue regeneration, enhance wound healing, and develop functional organ substitutes. Research addresses cellular differentiation, immunomodulation, vascularization, and extracellular matrix remodeling to optimize therapeutic outcomes. Our page compiles the latest peer-reviewed studies and patented प्रौद्योगिकियों advancing regenerative strategies, biomaterial innovations, and clinical applications that redefine approaches to tissue repair and organ replacement.
यह पुनर्योजी चिकित्सा पर अंग्रेजी में विश्वव्यापी प्रकाशनों और पेटेंटों का हमारा नवीनतम चयन है, कई वैज्ञानिक ऑनलाइन पत्रिकाओं के बीच, जिन्हें वर्गीकृत किया गया है और स्टेम कोशिका, ऊतक इंजीनियरिंग, सेल थेरेपी, बायोमटेरियल, मचान निर्माण, प्रेरित प्लुरिपोटेंट स्टेम कोशिका, पुनर्योजी मचान, एक्स्ट्रासेलुलर मैट्रिक्स, अंग पुनर्जनन, 3डी बायोप्रिंटिंग, विकास कारक, मेसेनकाइमल स्टेम कोशिका, कोशिका विभेदन, जीन संपादन, घाव भरना, पुनर्योजी बायोमटेरियल, कोशिका प्रत्यारोपण, इम्यूनोमॉड्यूलेशन, ऊतक पुनर्जनन, सेलुलर रीप्रोग्रामिंग, जैवसक्रिय अणु, वैस्कुलराइजेशन, पुनर्योजी थेरेपी, ऑटोलॉगस कोशिका, एलोजेनिक कोशिका, पुनर्योजी प्रत्यारोपण, कोशिका विस्तार, मैट्रिक्स रीमॉडलिंग और पुनर्योजी सूक्ष्मवातावरण पर केंद्रित किया गया है।
System for the production of advanced therapy manufactured products (atmps)
Patent published on the 2026-05-28 in WO under Ref WO2026112201 by SEDNA CELL CARE CORP [US] (Figueroa Rogelio [us], Stephens Erin [us], Benedict Michael [us], Gonzalez Arturo [us], Santell Manuel [us])
Abstract: A device and system for the medical processing of advanced therapy medicinal products. The system featuring a processing unit operating with a disposable fluid-container assembly constitutes a fully closed, self-contained manufacturing environment for cell-therapy production — including washing, enrichment, activation, genetic modification, expansion, media exchanges, in-process sampling, formulation, and final harvest of the produced cell therapy products.[...]
Our summary: The system is designed for the production of advanced therapy medicinal products. It includes a processing unit with a disposable fluid-container assembly for a fully closed manufacturing environment. The system supports various processes such as washing, activation, and final harvest of cell therapy products.
advanced therapy, manufacturing system, cell therapy, closed processing
Patent
Compositions and methods for induced stem cell differentiation to oligodendrocytes
Patent published on the 2026-05-28 in WO under Ref WO2026112110 by EXIR INC [US] (Roodgar Morteza [us])
Abstract: A method of differentiating nonhuman primate induced pluripotent stem cells (iPSCs) to oligodendrocytes is provided. The method may include providing a modified vector comprising a piggyBac vector backbone that expresses one or more differentiation factor genes, including SOX10, OLIG2, and NKX6-2. The piggyBac vector backbone may comprise one or more terminal inverted repeats and one or more transposase recognition sites configured to interact with a piggyBac transposase to mediate genomic integ[...]
Our summary: The method describes differentiating nonhuman primate iPSCs into oligodendrocytes using a modified piggyBac vector. This vector expresses key differentiation factors such as SOX10, OLIG2, and NKX6-2. The differentiated cells are identified by specific oligodendrocyte-associated markers.
iPSCs, oligodendrocytes, piggyBac vector, differentiation factors
Patent
Microcavity bioreactors and systems for 3d cell culture
Patent published on the 2026-05-28 in WO under Ref WO2026111867 by CORNING INCORPORATED [US] (Fang Ye [us])
Abstract: A microcavity bioreactor is provided that allows cell growth and cell differentiation in the same vessel, such that higher order three-dimensional cell cultures such as organoids can be generated in a singular vessel. The microcavity bioreactor may be part of a microcavity bioreactor system that allows for perfusion based cell culture and perfusion based cell harvesting. The microcavity bioreactor includes at least one, and preferably at least two, fluid distributor structures in the housing ves[...]
Our summary: Microcavity bioreactors enable simultaneous cell growth and differentiation in a single vessel. They facilitate the generation of higher-order 3D cell cultures like organoids. The system incorporates fluid distributor structures for enhanced perfusion-based culture and harvesting.
microcavity bioreactor, 3D cell culture, organoids, perfusion
Patent
Method of synthesis of testosteronan polymer and derivatives and uses thereof
Patent published on the 2026-05-28 in WO under Ref WO2026112535 by WEKA BIOSCIENCES LLC [US] (Otto Nigel J [us])
Abstract: Embodiments of the present invention provides recombinant systems, methods, and compositions for the biological production of Testosteronan (Testan), a linear α-(1→4)-linked glucuronic acid–N-acetylglucosamine polysaccharide. Microbial hosts engineered to express full-length CtTS, N-terminal truncation variants (including d64-CtTS), or the Pseudomonas CIPTS homolog synthesize high–molecular-weight Testan (≥800 kDa) with low polydispersity. Structural analysis by ¹H NMR and 2D HSQC demo[...]
Our summary: The invention details a method for synthesizing Testosteronan (Testan) using engineered microbial hosts. It includes purification techniques to obtain defined molecular-weight fractions and sulfated derivatives. Additionally, it outlines applications for Testan in chromatographic stationary phases and biomaterial scaffolds.
Testosteronan, microbial synthesis, polysaccharide derivatives, chromatographic applications
Patent
Identification and validation of fetal hemogobin-induction by idasanutlin for the treatment of sickle cell disease
Patent published on the 2026-05-28 in WO under Ref WO2026107592 by NARENDRAN ARUMUGAVADIVEL [CA] (Narendran Arumugavadivel [ca], Sipila Patrick [ca], Thakur Satbir [ca])
Abstract: The present application relates to the use of idasanutlin, or a pharmaceutically acceptable salt, a solvate, an isomer, or a functional derivative thereof for the treatment of hemoglobinopathies, including sickle cell disease, thalassemia, sickle cell beta thalassemia (Hb S/β Th), and leukocytosis as well as myeloproliferative conditions, polycythemia, and acute and chronic hemolytic anemia. It was found that idasanutlin increases HbF levels in multipotent erythroleukemia, hematopoietic stem ce[...]
Our summary: Idasanutlin is used to treat sickle cell disease and other hemoglobinopathies. It increases fetal hemoglobin (HbF) levels in relevant cell types. This provides a potential new therapy for managing sickle cell disease.
Idasanutlin, fetal hemoglobin, sickle cell disease, hemoglobinopathies
Patent
Method for producing cultured meat, and cultured meat
Patent published on the 2026-05-21 in WO under Ref WO2026105820 by ITOHAM YONEKYU HOLDINGS INC [JP] (Matsusaki Michiya [jp], Yamada Asuka [jp], Nakadozono Oya Chika [jp], Sugiura Takuya [jp], Takasuga Akiko [jp])
Abstract: The present disclosure relates to a method for producing cultured meat, the method comprising: a washing step for bringing bovine tissue into contact with a washing liquid containing peracetic acid; a recovery step for recovering stem cells from the washed bovine tissue; a preparation step for preparing bio-ink containing the recovered stem cells and fragmented extracellular matrix components; a printing step for printing the bio-ink to form a structure containing the stem cells; and a culturing[...]
Our summary: The method involves washing bovine tissue with peracetic acid, recovering stem cells, and preparing a bio-ink. The bio-ink is printed to create a structure containing stem cells. Finally, the stem cells undergo differentiation induction culturing to form a tissue body.
cultured meat, stem cells, bio-ink, tissue engineering
Patent
Joint material and shape optimization of a 3D printing nozzle by CFD and response surface methodology
Published on 2026-03-12 by @OXFORD
Abstract: AbstractThree-dimensional printing (3D printing) has emerged as a transformative technology in medicine, enabling the fabrication of complex structures with high precision. In bioprinting, optimization of nozzle design is essential to balance print resolution, mechanical strength, and biocompatibility. This study presents a computational framework for optimizing bioprinting performance by simultaneously accounting for nozzle geometry and biomaterial rheological properties. Using computational fl[...]
Our summary: This study presents a computational framework for optimizing bioprinting by integrating nozzle geometry and biomaterial properties. It utilizes CFD and response surface methodology to identify optimal nozzle configurations. Results show significant improvements in flow rate and reductions in wall shear stress, demonstrating the effectiveness of the approach.
3D printing, nozzle optimization, computational fluid dynamics, response surface methodology
Publication
Mechanisms, Effects, and Applications
Published on 2026-02-03 by Maryam Dastan, Ellen Dyminski Parente Ribeiro, Ursula Bellut-Staeck, Juan Zhou, Christian Lehmann @MDPI
Abstract: Infrasound, physically defined as sound at frequencies below 20 Hertz, can travel long distances with minimal attenuation and permeate biological tissues due to its marked particle displacement and deep penetration. Generated by both natural phenomena and human-made systems, infrasound has drawn increasing scientific and public attention regarding its potential physiological and psychological effects. Experimental studies demonstrate that infrasound can modulate mechanosensitive structures at th[...]
Our summary: Infrasound is sound below 20 Hertz that can penetrate biological tissues. It has both harmful and beneficial effects depending on intensity and frequency. Future research is needed to standardize exposure metrics and clarify health risks and therapeutic applications.
Infrasound, physiological effects, mechanosensitive structures, exposure assessment
Publication
